Factors affecting membrane-controlled drug release for an osmotic pump tablet (OPT) utilizing (SBE)(7m)-beta-CD as both a solubilizer and osmotic agent.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Journal of Controlled Release

• Publication date

  1999-08-05

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0168-3659(99)00077-2PMID 10425336
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Solubility-Modulated Osmotic Pump: In Vitro/in Vivo Release of Diltiazem Hydrochloride

  2004cited by this paper
• Release of testosterone from an osmotic pump tablet utilizing (SBE)7m-beta-cyclodextrin as both a solubilizing and an osmotic pump agent.

  1999cited by this paper
• Design and evaluation of an osmotic pump tablet (OPT) for chlorpromazine using (SBE)7m-beta-CD.

  1999cited by this paper
• Design and evaluation of an osmotic pump tablet (OPT) for prednisolone, a poorly water soluble drug, using (SBE)7m-beta-CD.

  1998cited by this paper
• Porosity-controlled ethylcellulose film coating. IV: Evaluation of mechanical strength of porous ethylcellulose film

  1994cited by this paper
• Porosity-controlled ethylcellulose film coating. II. Spontaneous porous film formation in the spraying process and its solute permeability

  1994cited by this paper
• Effects of Plasticizers on Water Permeation and Mechanical Properties of Cellulose Acetate: Antiplasticization in Slightly Plasticized Polymer Film

  1993cited by this paper
• Porosity-Controlled Ethylcellulose Film Coating. I. Formation of Porous Ethylcellulose Film in the Casting Process and Factors Affecting Film-Density.

  1993cited by this paper
• Controlled porosity solubility- and resin-modulated osmotic drug delivery systems for release of diltiazem hydrochloride

  1991cited by this paper
• Use of Modified Ethylcellulose Lattices for Microporous Coating of Osmotic Tablets

  1991cited by this paper
• Theophylline tablets coated with aqueous latexes containing dispersed pore formers.

  1990cited by this paper
• Mechanism of water transport in controlled porosity osmotic devices

  1989cited by this paper
• Osmotic water transport through cellulose acetate membranes produced from a latex system.

  1987cited by this paper
• Osmotic flow through controlled porosity films: An approach to delivery of water soluble compounds

  1985cited by this paper
• The permeability of enteric coatings and the dissolution rates of coated tablets

  1982cited by this paper
• Semipermeable membranes of cellulose acetate for desalination in the process of reverse osmosis. II. Parameters affecting membrane gel structure

  1965cited by this paper

• Modelling the controlled drug release of push-pull osmotic pump tablets using DEM.

  2024cites this paper
• Strategies to design push-pull osmotic systems for delivering low and pH-dependent soluble drugs

  2018cites this paper
• Zero-order release and bioavailability enhancement of poorly water soluble Vinpocetine from self-nanoemulsifying osmotic pump tablet

  2018cites this paper
• Cellulose Acetate Butyrate: Ammonio Methacrylate Copolymer Blends as a Novel Coating in Osmotic Tablets

  2017cites this paper
• Inclusion Complex of Podophyllotoxin with γ‐Cyclodextrin: Preparation, Characterization, Anticancer Activity, Water‐Solubility and Toxicity

  2016cites this paper
• Basic Concepts in Drug Targeting: A Versatile Supramolecular System for Drug Delivery

  2016cites this paper
• Design of a timed and controlled release osmotic pump system of atenolol

  2015cites this paper
• A REVIW ON OSMOTICALLY DRUG DELIVERY SYSTEM

  2014cites this paper
• A review on recent innovation in osmotically contro lled drug delivery system

  2014cites this paper
• Micro-porous surfaces in controlled drug delivery systems: design and evaluation of diltiazem hydrochloride controlled porosity osmotic pump using non-ionic surfactants as pore-former

  2014cites this paper
• The Effect of Pore-Formers and Plasticizers on the Release Kinetic of Diltiazem Hydrochloride from the Controlled Porosity Osmotic Pumps

  2013cites this paper
• Application of Cellulose and Cellulose Derivatives in Pharmaceutical Industries

  2013cites this paper
• Development and Evaluation of Swellable Elementary Osmotic Pump Tablets of Metoprolol Succinate and Ramipril

  2013cites this paper
• Formulation Development and Evaluation of Osmotic Drug Delivery System

  2012cites this paper
• [Novel approach of cyclodextrin-based pharmaceutical formulation].

  2012cites this paper
• Development and Optimization of Controlled Drug Release Formulation of Diclofenac Sodium Based on Osmotic Technology

  2012cites this paper
• Formulation and Evaluation of Controlled Porosity Osmotic Tablets of Lornoxicam

  2012cites this paper
• Advanced Technologies for Oral Controlled Release: Cyclodextrins for Oral Controlled Release

  2011cites this paper
• Development and In Vitro/In Vivo Evaluation of Etodolac Controlled Porosity Osmotic Pump Tablets

  2011cites this paper
• Cyclodextrins as Smart Excipients in Polymeric Drug Delivery Systems

  2011cites this paper
• Development and Optimization of Micro/Nanoporous Osmotic Pump Tablets

  2010cites this paper
• Osmotically controlled drug delivery system with associated drugs.

  2010cites this paper
• CONTROLLED RELEASE TECHNOLOGY AND DESIGN OF ORAL CONTROLLED RELEASE DOSAGE FORMS

  2010cites this paper
• CONTROLLED-POROSITY OSMOTIC PUMP TABLETS-AN OVERVIEW

  2010cites this paper
• Release mechanisms of a sparingly water-soluble drug from controlled porosity-osmotic pump pellets using sulfobutylether-beta-cyclodextrin as both a solubilizing and osmotic agent.

  2009cites this paper
• Characterization of an ultrafiltration membrane modified by sorption of branched polyethyleneimine

  2009cites this paper
• Oral osmotically driven systems: 30 years of development and clinical use.

  2009cites this paper
• Developments and new applications of UV-induced surface graft polymerizations

  2009cites this paper
• Characterization of charge properties of an ultrafiltration membrane modified by surface grafting of poly(allylamine) hydrochloride.

  2009cites this paper
• Design of a 24-hour controlled porosity osmotic pump system containing PVP: formulation variables

  2009cites this paper
• A new type of double-layered osmotic pump controlled release tablets of bezafibrate with poor water solubility and large dosage

  2008cites this paper
• Cyclodextrin based novel drug delivery systems

  2008cites this paper
• Controlled porosity-osmotic pump pellets of a poorly water-soluble drug using sulfobutylether-beta-cyclodextrin, (SBE) 7M-beta-CD, as a solubilizing and osmotic agent.

  2007cites this paper
• Controlled porosity‐osmotic pump pellets of a poorly water‐soluble drug using sulfobutylether‐β‐cyclodextrin, (SBE)7M‐β‐CD, as a solubilizing and osmotic agent

  2007cites this paper
• The utility of cyclodextrins for enhancing oral bioavailability.

  2007cites this paper
• Characterization of prednisolone in controlled porosity osmotic pump pellets using solid-state NMR spectroscopy.

  2007cites this paper
• Studies on Bi-Layer Osmotic Pump Tablets of Water-Insoluble Allopurinol with Large Dose: In Vitro and In Vivo

  2007cites this paper
• Mechanistic Investigation of Drug Release from Asymmetric Membrane Tablets: Effect of Media Gradients (Osmotic Pressure and Concentration), and Potential Coating Failures on In Vitro Release

  2007cites this paper
• Sistemas osmóticos de administración oral

  2006cites this paper
• Atomic force microscopy study of membranes modified by surface grafting of cationic polyelectrolyte

  2005cites this paper
• Osmotic pumps in drug delivery.

  2004cites this paper
• Studies on controlled release effervescent osmotic pump tablets from Traditional Chinese Medicine Compound Recipe.

  2004cites this paper
• [Pharmaceutical application of cyclodextrins as multi-functional drug carriers].

  2004cites this paper
• Design and evaluation of cyclodextrin-based drug formulation.

  2004cites this paper
• Development and evaluation of extended release formulations of isosorbide mononitrate based on osmotic technology.

  2003cites this paper
• Use of a Fluidized Bed Hammer Mill for Size Reduction and Classification: Effects of Process Variables and Starting Materials on the Particle Size Distribution of Milled Lactose Batches

  2003cites this paper
• The Pharmaceutical Use of Captisol®: Some Surprising Observations

  2002cites this paper
• Formulation aspects in the development of osmotically controlled oral drug delivery systems.

  2002cites this paper
• Cyclodextrin Complex Osmotic Tablet for Glipizide Delivery

  2002cites this paper
• Evolution of the Patent for Osmotic Drug Delivery

  2002cites this paper